Motor Development and Orthoses in Spinal Muscular Atrophy (SMA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00961103|
Recruitment Status : Unknown
Verified August 2009 by Arcispedale Santa Maria Nuova-IRCCS.
Recruitment status was: Not yet recruiting
First Posted : August 18, 2009
Last Update Posted : August 18, 2009
Spinal Muscular Atrophy (SMA) is neurodegenerative disease of anterior horn cells of spinal cord and represents the second more frequent pathology in childhood.
According to the age of onset and the maximum motor function the disorder is classified in 4 types. Patients with SMA II and SMA III often use orthoses to achieve postural and dynamic functions.
In this retrospective observational study the investigators describe the characteristics of sitting position, standing and walking correlated to type and time of orthoses used.
|Condition or disease|
|Spinal Muscular Atrophy|
We collect data from patients with SMA II and SMA III referred to UDGEE from jan. 1995 to dec. 2008.
We estimate to achieve informations about 50-70 patients.
|Study Type :||Observational|
|Estimated Enrollment :||70 participants|
|Official Title:||Assessment of Motor Development Related to Use of Orthoses in SMA II and III|
|Study Start Date :||September 2009|
|Estimated Primary Completion Date :||November 2009|
|Estimated Study Completion Date :||December 2009|
SMA II and SMA III
patients with SMA II and SMA III
- time and percentage of sitting, standing, walking achievement in SMA II and SMA III [ Time Frame: aug.2009- nov.2009 ]
- characteristics and percentage of orthoses for postural sitting control , standing and walking in SMA II and SMA III [ Time Frame: aug. 2009 - dec.2009 ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00961103
|Contact: Manuela Lodesani, MD||+390522296184 ext firstname.lastname@example.org|
|UDGEE Hospital S.Maria Nuova||Not yet recruiting|
|Reggio Emilia, RE, Italy, 42100|
|Contact: Manuela Lodesani, MD +390522296184 ext 5962 email@example.com|
|Sub-Investigator: Mariacristina Filippi, PT|
|Study Director:||Adriano Ferrari, MD||Hospital S.Maria Nuova Reggio Emilia Italy|